Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Lisa Taylor

Concepts (133)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Amyloid beta-Peptides
5
2025
251
0.600
Why?
Thrombocytopenia
2
2005
206
0.390
Why?
Memory, Episodic
2
2023
58
0.370
Why?
Alzheimer Disease
3
2025
641
0.280
Why?
Pharmaceutical Services
1
2008
76
0.260
Why?
Valproic Acid
1
2007
45
0.250
Why?
Heparin
2
2005
247
0.250
Why?
Saline Solution, Hypertonic
1
2007
43
0.250
Why?
Drug Utilization Review
1
2007
60
0.250
Why?
Telomerase
2
2010
252
0.240
Why?
Education, Pharmacy
1
2008
125
0.240
Why?
Medical Records
1
2007
193
0.240
Why?
NAD
2
2002
80
0.220
Why?
Crystallins
2
2002
60
0.210
Why?
Temporal Lobe
1
2025
112
0.210
Why?
Retinoblastoma Protein
1
2004
63
0.210
Why?
Thromboembolism
1
2005
129
0.200
Why?
Lens, Crystalline
2
2002
136
0.200
Why?
Frontal Lobe
1
2025
159
0.200
Why?
Glutathione
2
2002
369
0.190
Why?
Saliva
1
2025
256
0.190
Why?
Community Participation
1
2024
128
0.190
Why?
Anticoagulants
2
2005
746
0.190
Why?
Ultraviolet Rays
2
2002
376
0.180
Why?
Memory Disorders
1
2023
198
0.180
Why?
Kynurenine
1
2002
114
0.170
Why?
Memory
1
2023
298
0.160
Why?
Health Status Disparities
1
2024
322
0.160
Why?
Cell Cycle Proteins
1
2004
630
0.160
Why?
Pediatrics
1
2008
1124
0.150
Why?
Fibroblasts
1
2004
1034
0.140
Why?
Positron-Emission Tomography
3
2025
343
0.140
Why?
Cognitive Dysfunction
1
2023
481
0.130
Why?
Cystic Fibrosis
1
2007
1164
0.120
Why?
Brain
2
2025
2991
0.110
Why?
Aniline Compounds
2
2025
120
0.100
Why?
Drug and Narcotic Control
1
2012
24
0.090
Why?
Nonprescription Drugs
1
2012
68
0.090
Why?
Anti-Obesity Agents
1
2012
67
0.090
Why?
United States Food and Drug Administration
1
2012
208
0.090
Why?
Hydrogen-Ion Concentration
2
2002
534
0.080
Why?
Humans
15
2025
146342
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2010
104
0.070
Why?
Overweight
1
2012
614
0.070
Why?
Phenytoin
1
2007
21
0.060
Why?
Phenobarbital
1
2007
22
0.060
Why?
Hyperammonemia
1
2007
17
0.060
Why?
Hallucinations
1
2007
33
0.060
Why?
Metabolic Clearance Rate
1
2007
115
0.060
Why?
Aged
5
2025
26432
0.060
Why?
Telomere
1
2010
300
0.060
Why?
Guidelines as Topic
1
2008
267
0.060
Why?
Fructose
1
2007
132
0.060
Why?
Infusions, Intravenous
1
2007
432
0.060
Why?
Ethylene Glycols
1
2025
17
0.060
Why?
Plaque, Amyloid
1
2025
20
0.060
Why?
Pipecolic Acids
1
2005
26
0.060
Why?
Migraine Disorders
1
2007
109
0.060
Why?
Hirudins
1
2005
52
0.050
Why?
Tumor Suppressor Protein p53
2
2010
530
0.050
Why?
Anticonvulsants
1
2007
253
0.050
Why?
Administration, Oral
1
2007
872
0.050
Why?
New Mexico
1
2024
106
0.050
Why?
Drug Therapy, Combination
1
2007
1036
0.050
Why?
Clone Cells
1
2004
259
0.050
Why?
Endothelial Cells
1
2010
876
0.050
Why?
Arginine
1
2005
264
0.050
Why?
RNA
1
2010
926
0.050
Why?
Substance-Related Disorders
1
2012
1100
0.050
Why?
Antibodies
1
2005
400
0.050
Why?
Entorhinal Cortex
1
2022
15
0.050
Why?
Cell Division
1
2004
736
0.050
Why?
Cell Death
1
2004
379
0.050
Why?
Seizures
1
2007
489
0.050
Why?
Acrylates
1
2002
48
0.050
Why?
Benzoates
1
2002
48
0.050
Why?
Aged, 80 and over
2
2025
8391
0.050
Why?
Orthopedic Procedures
1
2005
260
0.050
Why?
Glucosides
1
2002
56
0.040
Why?
Benchmarking
1
2023
193
0.040
Why?
Cellular Senescence
1
2004
225
0.040
Why?
Recombinant Proteins
1
2005
1361
0.040
Why?
Middle Aged
4
2025
36619
0.040
Why?
Clinical Trials as Topic
1
2007
1064
0.040
Why?
Male
6
2025
73396
0.040
Why?
Peptide Fragments
1
2025
693
0.040
Why?
Cell Survival
1
2004
1105
0.040
Why?
Sulfonamides
1
2005
594
0.040
Why?
Kinetics
1
2004
1553
0.040
Why?
Platelet Aggregation Inhibitors
1
2005
499
0.040
Why?
Immunoglobulin G
1
2005
901
0.040
Why?
Female
6
2025
79499
0.040
Why?
Ascorbic Acid
1
2002
183
0.040
Why?
Neuropsychological Tests
1
2025
1149
0.040
Why?
Cattle
1
2002
940
0.040
Why?
Cell Line
1
2004
2814
0.040
Why?
Chronic Disease
1
2024
1827
0.030
Why?
Referral and Consultation
1
2024
881
0.030
Why?
Blood Pressure
1
2024
1765
0.030
Why?
DNA-Binding Proteins
1
2004
1468
0.030
Why?
Hippocampus
1
2022
989
0.030
Why?
Cognition
1
2023
1292
0.030
Why?
Time Factors
1
2005
7109
0.030
Why?
Biomarkers
1
2025
4340
0.020
Why?
Behind-the-Counter Drugs
1
2012
1
0.020
Why?
Health Planning Guidelines
1
2012
23
0.020
Why?
Laxatives
1
2012
22
0.020
Why?
Lactones
1
2012
60
0.020
Why?
Adolescent
2
2012
22557
0.020
Why?
Treatment Outcome
1
2007
11821
0.020
Why?
Child, Preschool
1
2007
11913
0.020
Why?
Adult
2
2025
41087
0.020
Why?
Lung
1
2004
4122
0.020
Why?
Hydroxylamines
1
2010
8
0.020
Why?
Telomeric Repeat Binding Protein 1
1
2010
6
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2010
74
0.020
Why?
Retroviridae
1
2010
99
0.020
Why?
Transduction, Genetic
1
2010
129
0.020
Why?
Magnetic Resonance Imaging
1
2022
3926
0.020
Why?
Cell Hypoxia
1
2010
249
0.020
Why?
Bone Marrow Cells
1
2010
328
0.020
Why?
Genetic Vectors
1
2010
327
0.020
Why?
Retrospective Studies
1
2007
17438
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
974
0.020
Why?
Young Adult
1
2025
14330
0.020
Why?
Blotting, Western
1
2010
1177
0.020
Why?
Pilot Projects
1
2012
1888
0.020
Why?
Child
1
2007
22693
0.020
Why?
Oxidative Stress
1
2010
1369
0.010
Why?
Cell Proliferation
1
2010
2502
0.010
Why?
Cells, Cultured
1
2010
4118
0.010
Why?
Animals
1
2002
38107
0.010
Why?
United States
1
2012
16136
0.010
Why?
Taylor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)